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AbstrAct
Progressive realisation is invoked as the guiding principle 
for countries on their own path to universal health 
coverage (UHC). It refers to the governmental obligations 
to immediately and progressively move towards the 
full realisation of UHC. This paper provides procedural 
guidance for countries, that is, how they can best organise 
their processes and evidence collection to make decisions 
on what services to provide first under progressive 
realisation. We thereby use ‘evidence-informed deliberative 
processes’, a generic value assessment framework to 
guide decision making on the choice of health services. We 
apply this to the concept of progressive realisation of UHC.
We reason that countries face two important choices to 
achieve UHC. First, they need to define which services 
they consider as high priority, on the basis of their social 
values, including cost-effectiveness, priority to the worse 
off and financial risk protection. Second, they need to 
make tough choices whether they should first include more 
priority services, first expand coverage of existing priority 
services or first reduce co-payments of existing priority 
services. Evidence informed deliberative processes can 
facilitate these choices for UHC, and are also essential 
to the progressive realisation of the right to health. The 
framework informs health authorities on how they can best 
organise their processes in terms of composition of an 
appraisal committee including stakeholders, of decision-
making criteria, collection of evidence and development 
of recommendations, including their communication. 
In conclusion, this paper fills in an important gap in the 
literature by providing procedural guidance for countries to 
progressively realise UHC. 
IntroductIon
Sustainable development goal (SDG) 3.8 seeks 
to achieve universal health coverage (UHC), 
including financial risk protection, access to 
quality essential healthcare services and access 
to safe, effective, quality and affordable essen-
tial medicines and vaccines for all.1 Progressive 
realisation is invoked as the guiding principle 
for countries on their own path to UHC and 
achievement of the SDG health targets. It refers 
to the governmental obligations to immedi-
ately and progressively move towards the full 
realisation of UHC, recognising the constraints 
imposed by limited available resources.2 3
The WHO report ‘Making fair choices on the 
path to universal health coverage’ provides strategic 
advice to countries committed to achieving 
UHC.2 This paper follows up on the report, 
and provides procedural guidance to countries, 
that is, on how they can best organise their deci-
sion-making process to make well reasoned and 
publicly accountable choices on their path to 
UHC. It thereby fills an important gap in the 
literature. The paper is especially relevant for 
governmental health authorities, at national or 
subnational levels, in charge of overseeing and 
guiding the progress towards UHC.
To achieve UHC, countries must make 
important choices at two levels. First, they 
need to classify their services in priority classes. 
Prioritising services is not straightforward, 
and often involves difficult trade-offs between 
various values that a country finds important. 
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Key questions
What is already known about this topic?
 ► Countries are recommended to progressively realise 
universal health coverage, and to make explicit 
choices regarding the expansion of priority services, 
the inclusion of more people and reduction of out-of-
pocket payments.
 ► Countries should use fair processes to be 
accountable to their populations.
What are the new findings?
 ► This paper provides practical procedural guidance 
to countries on how they can best organise their 
decision-making process to make these choices in 
a well reasoned and publicly accountable manner.
recommendations for policy
 ► Countries are recommended to establish evidence-
informed deliberative processes.
 ► The use of these processes has consequences 
for the composition of an appraisal committee 
including stakeholders, choice of decision-making 
criteria, collection of evidence and development of 
recommendations, including their communication 
and options for appeal.
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Figure 1 Three dimensions to consider when moving to 
universal health coverage.
Countries may, for example, attach extra value to services 
that are cost-effective, target severe diseases or disadvan-
taged populations, and provide financial risk protection 
from the impoverishing impact of ill-health.2 Countries 
need to establish such a list of high priority services, and 
periodically update it, for example, every 4 years. Many 
countries may already have established their priority 
services in the context of their essential package of 
health services, as part of their strategy to achieve UHC. 
Examples are Chile, Ghana, Mexico, Nigeria, Rwanda, 
Thailand and Vietnam.4
Second, countries need to make difficult choices 
regarding the implementation of high priority services, in 
terms on what they do first (and next) on their path to UHC. 
Progressive realisation of UHC is specifically related to these 
types of incremental decisions. Countries can advance in 
at least three dimensions: include more priority services in 
the essential package, expand coverage of existing priority 
services to non-covered populations or reduce out-of-pocket 
payments for existing priority services (figure 1).2 We call 
these implementation options. For example, implementa-
tion options may be to increase the coverage of skilled birth 
attendance by making it available to all rural populations, or 
to reduce co-payments for antibiotic treatment of children 
with pneumonia. Which implementation option they choose 
to do first may have far-reaching consequences for the level 
and distribution of health in the country, and of financial 
risk protection. Countries should therefore recognise that 
these choices should preferably be made among implemen-
tation options on all three dimensions simultaneously. We 
consider this interpretation of progressive realisation, in 
terms of making choices among a set of implementation 
options, as a further operationalisation of the mentioned 
WHO report.2 Countries should make these choices on a 
recurrent, ongoing basis, always within the envelope of avail-
able resources in current and future fiscal years.
This paper is organised as follows. The next section 
spells out the core principles of public accountability, 
and required processes for progressive realisation of 
UHC. Following sections provide guidance on the clas-
sification of services in priority classes, and on how to 
choose between implementation options in terms of what 
to do first. The final section puts these issues in a broader 
perspective.
PublIc AccountAbIlIty
In making choices between services and implementation 
options on the path to UHC, health authorities should be 
accountable to the populations they serve. Information 
about their decisions and actions should be transparently 
available in accessible formats, which requires freedom 
of information laws; authorities should be required to 
justify their criteria and decisions when questioned; and 
remedies should be available when agreed-upon services 
are not available in practice, or when such decisions have 
been shown to be arbitrary or discriminatory. The public’s 
role is to actively hold the health authorities accountable, 
but institutions such as Ombuds offices, courts and other 
independent review mechanisms are required to ensure 
effective enjoyment of health rights in practice.5
Meaningful public accountability can facilitate 
progressive realisation of UHC in various ways. It forces 
decision makers to be more systematic, explicit and trans-
parent, by making decisions sensitive to a wider range of 
needs and values, and by promoting consistency across 
decisions. It can also make the implementation of deci-
sions more efficient by addressing disagreement at an 
earlier stage and by facilitating ownership, by discour-
aging fraud and waste, and by promoting collaboration 
within the community. Accountability is central to health 
systems and health reforms, including the post-2015 
development agenda.2
‘Evidence-informed deliberative processes’ is a value 
assessment framework that explicitly addresses this issue 
of public accountability, and builds on existing tools for 
health technology assessment such as ‘Accountability for 
Reasonableness’6 and ‘Multi-criteria decision analysis’.7 
The framework spells out how policy makers can best 
organise their processes.8 9 On the one hand, it is based 
on early, continued stakeholder deliberation to identify 
relevant values and to foster a shared understanding 
among stakeholders of these values. Stakeholders may 
be members of the public, but may also involve actors 
such as patient groups, health workers, hospitals, insurers 
or manufacturers, at the national or international level. 
These stakeholders each bring in important interests, 
values and considerations, and the framework aims to 
balance these interests, and foster decisions that are 
justifiable and considered reasonable by all involved 
stakeholders. On the other hand, evidence-informed 
deliberative processes are based on reasoned deci-
sion making—through evaluation of the identified values.
Health authorities in many countries already have a 
process in place which often involves stakeholders and 
uses evidence. But the way this is organised is often not 
ideal in terms of accountability—stakeholder involve-
ment is not meaningful or it comes late, and relevant 
values are not always identiﬁed in time or not at all. Also, 
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Figure 2 The organisation of evidence-informed 
deliberative processes. M&E, monitoring and evaluation. 
the collection of evidence on only a limited set of values 
is often incomplete. ‘Evidence-informed deliberative 
processes’ proposes a vision for how health authorities 
should ideally organise their process. This ideal should 
not be interpreted as a blueprint for authorities but 
rather as an aspirational goal; countries are advised to 
take incremental steps towards this goal.
FIrst choIce: the use oF evIdence-InFormed 
delIberAtIve Processes to IdentIFy hIgh-PrIorIty 
servIces
Health authorities first need to classify services in low-pri-
ority, medium-priority and high-priority classes, and they 
should periodically review this, for example, every 4 years. 
The use of evidence-informed deliberative processes has 
implications for the organisation of processes to support 
this (figure 2), and we discuss this for all six steps below.
step 1: situational analysis
The situational analysis serves to map out disease preva-
lence, severity, level of service coverage and of financial 
risk protection. The situational analysis should also iden-
tify relevant stakeholders.
step 2: establishment of an appraisal committee
Authorities are advised to establish an appraisal committee 
that steers the various activities in the decision-making 
process, and finally develops recommendations to the 
health authorities on which services should be classified 
as high priority. This committee should ideally comprise 
a variety of stakeholders as their members. Permanent 
members should be installed to advocate for the broad 
public interest. Temporary members can be included to 
represent specific stakeholders including their interests 
and expertise—making their appointment dependent on 
the recommendation under scrutiny. Temporary members 
do not have mandate to develop recommendations.
In certain countries, stakeholder participation in 
appraisal committees may not be possible. Alternatively, 
stakeholders can be involved through a citizen council as 
in the UK, or soliciting input and feedback from patients 
as in Canada and Scotland. Yet, meaningful stakeholder 
participation involves interaction and deliberation.9
step 3: Identification of interventions and criteria
Health authorities, in consultation with stakeholders, 
are advised to establish a list of services for appraisal. 
Health authorities are advised to identify explicit deci-
sion-making criteria for selecting high-priority services, 
with criteria referring to the formal operationalisation of 
stakeholders’ values. The WHO report ‘Fair choices on the 
path to UHC’ has proposed three such criteria2:
 ► Cost-effectiveness: Priority should be given to the 
most cost-effective policies. This is typically motivated 
by the goal of health maximisation, that is, to obtain as 
much benefit as possible from the available resources.
 ► Priority to the worse off: Priority should be given to 
the policies benefiting the worse off groups in terms 
of health and socioeconomic status. As to the lat-
ter, many countries face significant coverage gaps, 
especially among rural populations, the poor and 
marginalised groups due to gender, race or social 
status. This implies that an expansion of such ser-
vices to an underserved poor and rural population 
should take priority over an expansion to a well off, 
urban population, at least where other things are 
roughly equal. Reasons for this can be framed in 
terms of the importance of health and health ser-
vices to individuals and society, respect for the right 
to health and social solidarity relating to equal and 
affordable access.
 ► Financial risk protection: Out-of-pocket medical 
payments can lead to impoverishment within house-
holds. Protection from financial risks associated with 
healthcare expenses has emerged as a critical compo-
nent of national health strategies in many countries.
Other generic criteria (ie, criteria that are relevant 
across a broad selection of services) include ‘safety’ and 
‘effectiveness’ of services. In addition, ‘contextual’ criteria 
are relevant to further help classify high-priority services. 
These may relate to various considerations, for example, 
‘individual responsibility for health’ for services targeting 
behaviour-related diseases such as smoking.10
In order not to overlook criteria, health authorities are 
advised to develop a checklist including their range of 
generic and contextual criteria. Several classifications of 
decision criteria can be used as starting points for this.10–12 
The specification of criteria in such a checklist is important, 
as it may have far-reaching consequences for the choice of 
services—this should take place through a robust public 
deliberation and participatory procedure.13
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step 4: collection of evidence
Health authorities are advised to generate an evidence 
base on criteria. The evidence collection on safety and 
effectiveness of services is relatively well developed.14 
Also, methodological guidance for evidence collection on 
cost-effectiveness of services,15 16 and databases of evidence 
are available.17–19 Yet, health authorities may be required 
to make substantial investments to obtain timely and 
context-specific data on this. The collection of evidence on 
the criterion ‘priority to the worse off’ can, for example, 
be estimated by considering healthy life years lost.2 12 20 
Methods for the evidence collection on the criterion ‘finan-
cial risk protection’ are now being developed through the 
growing application of extended cost-effectiveness anal-
ysis.21
In the event that the abovementioned refined 
evidence on criteria cannot be generated, authorities 
are advised to use aggregated data or expert opinion. 
In addition, the use of evidence-informed deliberative 
processes will likely lead to the identification of further 
criteria, and these may also require further qualitative 
or quantitative assessment.
step 5: development of recommendations
In order to develop recommendations on the ranking 
of services into priority classes, the appraisal committee 
should make balanced judgements regarding the ranking 
of the various criteria, and the performance of services 
on these criteria. The committee can use different strate-
gies to arrive at these judgements.
One useful strategy is to start with the safety and effective-
ness considerations, as they are fundamental to approval 
of services in any health system, and to consider these as 
knockout criteria. Next, since health maximisation is a 
prime objective of many health systems, the committee 
can choose to initially classify services in priority classes on 
the basis of their cost-effectiveness (with ‘highly cost-effec-
tive’ services classified in the high-priority class, etc). The 
committee should define cost-effectiveness thresholds 
regarding these classes.22 23 All other criteria can affect this 
initial classification. The appraisal committee should make 
an overview of the performance of the various services on 
these criteria. Such an overview likely combines evidence 
of a quantitative or qualitative nature—depending on the 
nature of the criteria. For every criterion, the appraisal 
committee should argue whether and how it affects the 
priority class in which a service was initially classified (on 
the basis of its cost-effectiveness). Arguments brought to 
table should be subjected to deliberation, and in the end 
balanced against each other. The committee will even-
tually need to come to a final recommendation, thereby 
providing argumentation on which criteria are considered 
of overriding importance.9 The importance of deliberation 
regarding the full range of criteria cannot be underesti-
mated; quantitative decision aids such as weights can never 
fully replace reasoned judgements.24 The evidence to deci-
sion framework provides practical guidance including tools 
on how to organise this deliberative process.25
Interest groups in reality have different capacities to 
influence the prioritisation process, for example, in some 
countries there may be a more effective political lobby 
promoting cancer services over other services. More-
over, disadvantaged groups in society may face challenges 
that hinder their effective participation in deliberative 
processes.26 The challenge for the appraisal committee is 
to mitigate such differences, if present. Importantly, stake-
holder involvement in the appraisal committee does not 
necessarily need to lead to mutual consensus on a recom-
mendation, or to a joint decision. Thus, any particular 
stakeholder dominance or pressure from strong interest 
groups is only relevant to the extent the accountable health 
authority allows this.9 The final decision, and account-
ability, rests with the accountable health authority.
step 6: communication, appeal, regulation and enforcement, 
monitoring and evaluation
In a democratic society, policy makers hold the authority 
to make decisions and are accountable for the deci-
sion-making process. It is therefore important that health 
authorities communicate their decisions, including all 
reasons that have been put forward by the appraisal 
committee, to justify these decisions. Doing so in trans-
parent and accessible ways will increase the likelihood 
that stakeholders including citizens who did not partic-
ipate—and did not go through a learning process—can 
understand and accept the reasoning underlying the 
final decision.6
In addition, societal perceptions of what should 
count as legitimate arguments for recommendations 
are subject to change over time or with new evidence 
becoming available. Health authorities should 
therefore organise a revision and appeal or review 
mechanism.6 Additionally, the decisions taken must be 
implemented effectively through regulation, and be 
subject to enforcement.
Health authorities need a strong system for monitoring 
and evaluation, to promote accountability and to effectively 
pursue UHC in general. Authorities should carefully select 
a set of indicators tailoring SDG indicators to national 
priorities, invest in health information systems and prop-
erly integrate the information in policy making.2
second choIce: the use oF evIdence-InFormed 
delIberAtIve Processes to evAluAte hIgh PrIorIty 
servIce ImPlementAtIon oPtIons
Whereas health authorities first need to select 
high priority services (as discussed above), they subse-
quently need to decide on what to do first regarding 
different implementation options to make high priority 
services available. For these choices, the same kind of 
evidence-informed deliberative processes including the 
same appraisal committee can be employed, yet with 
the following specific characteristics.
First, choices on implementation options need to 
be made on an ongoing, recurrent basis. Second, the 
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Box Identifying high priority services in HIV/AIDS control 
in West Java province, Indonesia
In Indonesia, West Java is among the provinces with the highest HIV 
prevalence, and its provincial AIDS commission is responsible for 
coordination of HIV/AIDS activities. Here we describe the use of an 
evidence-informed deliberative process to select high-priority services 
for the 5 years (2014–2018) HIV/AIDS strategic plan of the AIDS 
commission.
The implementation followed similar steps as described in the 
main text to identify priority services, and was carried out by the West 
Java provincial AIDS commission (named health authorities hereafter), 
supported by Padjadjaran University in Bandung, and Radboud 
university medical centre in the Netherlands. In step 1, the health 
authorities analysed the HIV prevalence among key populations, its 
future spread and coverage of services, and conducted a stakeholder 
analysis to identify relevant stakeholders in West Java. In step 2, on 
the basis of this analysis, an appraisal committee was established 
including government staff from the health office, labour office, 
education office and the coordinating body for family planning (n=6); 
staff from community organisations working on family planning and 
representing people living with HIV/AIDS and high-risk groups (n=4); 
programme managers from the West Java AIDS commission (n=7); 
and researchers with backgrounds in economics and epidemiology 
working on HIV/AIDS at Padjadjaran University (n=6). In step 3, this 
committee discussed criteria to prioritise services, with, as inputs, 
the results of a local survey on the importance of criteria for priority 
setting, WHO treatment guidelines, and implicit criteria used during 
the development of former National and West Java strategic plans. 
Each committee member first identified his/her own top five criteria, 
and these were subsequently discussed together, resulting in the 
following criteria: ‘impact on the epidemic’, ‘stigma reduction’, 
‘cost-effectiveness’ and ‘universal coverage’. In addition, a larger 
group of 70 stakeholders proposed a total of 50 services for potential 
prioritisation in the strategic plan. In step 4, the health authorities 
collected evidence on the performance of these services on all 
criteria, on the basis of international literature, a locally adapted 
HIV disease model, and, if necessary, expert opinion. All evidence, 
including a grading of its quality, was presented as scores in a 
performance matrix. In step 5, on the basis of this matrix, and in 
a deliberative process, the appraisal committee agreed on high-
priority services. In step 6, the appraisal committee developed an 
implementation plan, in terms of task division and the identification 
of funders per service. The results of the priority setting process were 
included in West Java’s 5-year (2014–2018) strategic document for 
HIV/AIDS control, which was presented to the governor for approval in 
2016.
This example illustrates the use of an evidence-informed 
deliberative process to select high-priority services (as spelled out in 
section 3 of the main text), with the exception of organising activities 
related to communication, appeal, or monitoring and evaluation 
mechanisms.
appraisal committee should identify implementation 
options in terms of including more services in the essen-
tial package, expanding the coverage of specific services 
and/or reducing co-payments for specific services. 
For example, at a certain point in time, an appraisal 
committee may define the following implementation 
options: (1) expanding coverage of measles vaccine to 
rural populations without co-payments; (2) introducing 
malaria prophylaxis in urban areas with co-payments; 
and (3) eliminating co-payments for assisted deliveries at 
current coverage levels. The appraisal committee may also 
wish to define disinvestment options, to free up resources 
for investment in the progressive realisation of UHC. 
Third, the task of an appraisal committee is not restricted 
to develop strictly positive or negative recommendations. 
The above process may also lead to recommendations for 
price negotiation, or the collection of further evidence. 
Together with stakeholders, health authorities may also 
identify alternative ways of implementation of services, 
which may optimise their value.9
broAder consIderAtIons
This paper presents practical guidance for health author-
ities to make two important choices in the context of 
progressive realisation of UHC. The first type of choice 
relates to the classification of services in priority classes. 
In case where countries lack the analytical capacity to 
make these choices, they may also base their classifica-
tion on international recommendations in this context, 
for example, on the essential services for reproductive, 
maternal, newborn and child health.27 The second type 
of choice pertains to what health authorities should do, 
at a certain point in time, to implement these priorities. 
It is preferable for health authorities to explicitly define 
implementation options, defined in terms of a service, 
its coverage level and related co-payment, and use 
evidence-informed deliberative process to make these 
important choices. Health authorities are advised to 
make institutional arrangements that facilitate processes 
for making both types of choices.
Many health authorities often already have some sort of 
evidence-informed deliberative process in place,4 28 and we 
advise them to incrementally improve on these, according 
to local needs and affordances. For example, authori-
ties may decide to organise deliberation, or publish their 
argumentation vis-à-vis their recommendations. Various 
other proposed approaches to priority setting are based 
on the same principles of stakeholder deliberation and 
evidence gathering29 30—these may also provide important 
lessons for authorities. In general, these approaches 
comprise the same steps described in this paper.
The guidance provided here is centred around the 
concept of ‘progressive realization’ and is to be under-
stood in two different ways. First, as the progression 
towards UHC over time. Second, with ‘progressive’ being 
interpreted in the social sense as ensuring that equity 
concerns are fully considered in decision making, such 
as reducing coverage gaps of essential services for those 
currently left behind.31
To be truly robust, accountability and participation 
mechanisms should be institutionalised. Many countries 
that have succeeded in moving towards UHC—such as 
Mexico, Rwanda, Thailand, and Turkey—have created 
innovative institutions that promote accountability 
and participation.4 These can surely be strengthened. 
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Nevertheless, when robust participation and account-
ability are included, and protections against legal and de 
facto discrimination accompany it, such an evidence-in-
formed deliberative process is consistent with priority 
setting for the progressive realisation of the right to 
health. The latter is recognised by virtually every country 
in the world through the international treaties states have 
ratified, and is increasingly enshrined and enforced in 
national legal systems.5 32
This paper provides technical guidance to countries on 
how to make service choices on their path to UHC, and 
addresses various political aspects, such as stakeholder 
involvement and development of recommendations in 
the context of stakeholder dominance. Yet, it does not 
address broader political issues such as the role of pres-
sure groups on determining the total budget envelop for 
healthcare and therefore UHC. These issues are never-
theless important for countries to consider in their efforts 
to achieve UHC, and further integration of political 
sciences in the development of methods for healthcare 
priority setting is critical.33
Finally, achieving UHC also requires broad health 
financing changes, such as increasing mandatory, 
progressive prepayment with pooling of funds.34
conclusIon
The use of evidence-informed deliberative processes fills in 
an important gap in the literature on UHC. It responds to 
key questions that countries have, that is, how they can best 
organise their processes and evidence collection to make 
decisions on what services to provide first under progres-
sive realisation. In this way, the framework contributes to 
the quest of countries to progressively realize UHC as an 
important SDG.
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